Udaipur : In a defining leap for Indian medical technology on the global stage, SS Innovations International — the makers of the indigenous SSI Mantra surgical robotic system — has been listed on NASDAQ. Trading is expected to commence on April 25, 2025, with the company’s shares listed under the ticker symbol ‘SSII’.
SS Innovations International reported impressive financial growth for the year ending December 31, 2024, with revenues reaching $20.6 million — a 3.5-fold increase from the previous year’s revenue of $5.9 million. Gross margins also showed significant improvement, rising to 40.9% from 12.3% in 2023, highlighting the company’s robust financial performance and expanding market presence.
Expressing immense happiness and gratitude over SS Innovations International’s debut on NASDAQ, Dr. Sudhir Srivastava, Founder, Chairman, and CEO, said, “Uplisting to NASDAQ marks an exciting milestone for SS Innovations International and reflects our team’s achievements in developing the world-class SSI Mantra Surgical Robotic System. This system offers top-tier quality, safety, efficiency, and affordability, enabling cutting-edge robotic surgical procedures for a wider range of patients globally. As a proud ‘Made in India for the world’ innovation, we are helping elevate India’s presence in the global healthcare landscape.”
